Toripalimab (PDCD1/PD1/CD279) - Research Grid Biosimilar
Kwaliteit
ISO Gecertificeerd
Levering
24-48 uur
Technische Specificaties
Toripalimab is humanized monoclonal antibody targeted at programmed death receptor 1 (PD-1), used to treat patients with unresectable or metastatic melanoma who have failed previous systemic system therapy, and is intended for treatment Breast cancer, lymphoma, malignant melanoma, urogenital cancer and other types of solid tumors.
Humanized / PDCD1/PD1/CD279 [Homo sapiens]
• Recombinant Monoclonal
Unconjugated
Primary Antibodies, Biosimilars
CHO cells
Cancer, Immunology
>95%
Batch dependent
PBS buffer pH7.5
None
Blue Ice
Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8 ˚ C for 1-2 weeks. Store at -20 ˚ C for 12 months. Store at -80 ˚ C for long term storage.
IgG4-kappa
Homo sapiens
Beschrijving
Toripalimab (PDCD1/PD1/CD279) - Research Grid Biosimilar Beschikbaar in 0.1 mg. Bestel eenvoudig online met snelle levering.
Specificaties
Recent bekeken producten
Arachis hypogaea Lectin (PNA) - Biotinylated
21510020-1
5mg
1,4- Dioxane Pure
1041330 500
500 mL
Benzonase ELISA Kit
EG23601S
96 Tests
Not I Restriction Enzyme
B2016623
500 Units
K562-HLA-G0101 Overexpressing Cell Line
RG-1214
5x 10^6
Yeast Poly (A) Polymerase
RNT-006-S
30000 Units
Arachis hypogaea lectin (PNA)
05-0116-10mg
10 mg
Anti-APOE2 mouse monoclonal antibody
TD-AB0132
100 µg